WEST PHARMACEUTICAL SERVICES, INC. (WST)

Import this data to Google Sheets with:

=jivedata("WST","financials")

Full statements spill as a table. For one cell: =jivedata("WST","Revenue") or =jivedata("WST","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

WEST PHARMACEUTICAL SERVICES, INC.

WST • CIK 0000105770

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$2,949,800	$2,893,200	$3,074,100	$3,326,800
Cost of Goods and Services Sold	$1,820,600	$1,894,700	$1,970,100	$2,103,000
Gross Profit	$1,129,200	$998,500	$1,104,000	$1,223,800
Research and Development Expense	$68,400	$69,100	$74,300	$74,400
Selling, General and Administrative Expense	$353,400	$338,500	$393,600	$426,800
Operating Income (Loss)	$676,000	$569,900	$584,900	$680,400
InterestExpenseNonoperating	—	$3,000	$500	$4,500
Investment Income, Net	$28,000	$19,600	$17,500	$18,700
Other Nonoperating Income (Expense)	$3,000	$-1,000	$-1,000	$-1,000
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest	$698,000	$585,500	$600,900	$693,600
Income Tax Expense (Benefit)	$122,300	$107,500	$121,600	$144,200
Income (Loss) from Equity Method Investments	$17,700	$14,700	$14,400	$15,500
Net Income (Loss) Attributable to Parent	$593,400	$492,700	$493,700	$564,900
Weighted Average Number of Shares Outstanding, Basic	74,300,000	73,000,000	72,300,000	71,400,000
Weighted Average Number of Shares Outstanding, Diluted	75,300,000	73,700,000	72,700,000	71,800,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$853,900	$484,600	$791,300	$435,800
Accounts Receivable, after Allowance for Credit Loss, Current	$512,000	$552,500	$574,400	$712,000
Property, Plant and Equipment, Gross	$2,738,000	$2,985,800	$3,223,400	$3,248,600
Inventory, Net	$434,700	$377,000	$443,900	$447,400
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$1,324,700	$1,404,200	$1,497,000	$1,562,300
Other Assets, Current	$135,800	$124,000	$168,600	$212,300
Property, Plant and Equipment, Net	$1,413,300	$1,581,600	$1,726,400	$1,686,300
Assets, Current	$1,936,400	$1,538,100	$1,978,200	$1,807,500
Operating Lease, Right-of-Use Asset	$99,200	$104,500	$117,000	$104,700
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	$210,000	$202,100	$212,300	$207,700
Goodwill	$108,500	$106,000	$109,900	$108,700
Intangible Assets, Net (Excluding Goodwill)	$15,100	$10,800	$7,700	$6,400
Deferred Income Tax Assets, Net	$25,700	$26,000	$38,400	$72,300
Other Assets, Noncurrent	$21,300	$74,300	$80,100	$82,800
Assets	$3,829,500	$3,643,400	$4,270,000	$4,076,400
Long-term Debt, Excluding Current Maturities	$72,800	$202,600	$202,800	$202,900
Deferred Income Tax Liabilities, Net	$12,700	$20,500	$23,000	$22,400
Liability, Defined Benefit Plan, Noncurrent	$29,600	$28,200	$29,000	$28,300
Operating Lease, Liability, Noncurrent	$84,500	$81,800	$95,600	$88,300
Deferred Compensation Liability, Classified, Noncurrent	$18,600	$15,400	$13,500	$13,900
Other Liabilities, Noncurrent	$58,500	$62,200	$75,200	$89,900
Liabilities	$948,500	$961,100	$1,094,000	$1,086,200
Accounts Payable, Current	$242,400	$239,300	$253,700	$252,700
Accrued Income Taxes, Current	$16,600	$31,500	$28,100	$64,700
Operating Lease, Liability, Current	$17,700	$17,900	$22,700	$20,900
Other Liabilities, Current	$155,200	$188,200	$214,500	$171,100
Liabilities, Current	$671,800	$550,400	$654,900	$640,500
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$18,800	$18,800	$18,800	$18,800
Additional Paid in Capital	$120,200	$22,100	$0	$0
Retained Earnings (Accumulated Deficit)	$3,523,400	$3,956,600	$4,374,900	$4,624,100
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-143,800	$-258,100	$-105,500	$-140,400
Treasury Stock, Common, Value	$637,600	$1,057,100	$1,112,200	$1,512,300
Stockholders' Equity Attributable to Parent	$2,881,000	$2,682,300	$3,176,000	$2,990,200
Preferred Stock, Shares Authorized	3,000,000	3,000,000	3,000,000	3,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	200,000,000	200,000,000	200,000,000	200,000,000
Common Stock, Shares, Issued	75,300,000	75,300,000	75,300,000	75,300,000
Common Stock, Shares, Outstanding	73,500,000	72,300,000	72,000,000	70,400,000
Treasury Stock, Common, Shares	1,800,000	3,000,000	3,300,000	4,900,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$593,400	$492,700	$493,700	$564,900
Net Cash Provided by (Used in) Operating Activities	$776,500	$653,400	$754,800	$662,200
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	—	$-21,400	$22,900	$-14,100
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-40,400	$-369,300	$306,700	$-73,900
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$853,900	$484,600	$791,300	$908,500
Depreciation	$133,700	$151,800	$168,600	$179,000
Payments to Acquire Property, Plant, and Equipment	$362,000	$377,000	$285,900	$225,300
Amortization	$3,600	$3,600	$2,800	$2,400
Payments for (Proceeds from) Other Investing Activities	$6,700	$1,700	$0	$0
Share-based Payment Arrangement, Noncash Expense	$23,300	$18,700	$23,800	$32,600
Net Cash Provided by (Used in) Investing Activities	$-368,700	$-378,700	$-285,900	$-225,300
Restructuring Reserve, Settled without Cash	$0	$0	$5,400	$5,700
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment	$-100	$0	$0	$0
Gain (Loss) on Disposition of Property Plant Equipment	$-11,600	$0	$0	$0
Asset Impairment Charges	$9,600	$7,300	$11,700	$11,800
Deferred Income Tax Expense (Benefit)	$37,500	$-3,500	$-13,700	$-13,700
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions	$14,300	$13,400	$10,500	$10,500
Other Noncash Income (Expense)	$-1,000	$4,700	$7,400	$5,500
Increase (Decrease) in Accounts Receivable	$-4,000	$58,800	$-6,900	$-6,900
Proceeds from Issuance of Debt	—	$164,700	$0	$0
Increase (Decrease) in Inventories	$13,500	$-42,000	$62,800	$62,800
Repayments of Long-term Debt	—	$169,000	$0	$0
Increase (Decrease) in Other Current Assets	$21,300	$5,800	$-9,700	$-9,700
Finance Lease, Principal Payments	—	$23,300	$1,100	$1,300
Increase (Decrease) in Accounts Payable	$4,400	$2,900	$17,900	$17,900
Payments of Ordinary Dividends, Common Stock	$57,000	$59,100	$61,200	$62,400
Increase (Decrease) in Other Operating Assets and Liabilities, Net	$-6,000	$-22,600	$-108,100	$-108,100
Proceeds from Stock Options Exercised	$43,900	$25,500	$11,300	$17,700
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised	$7,100	$7,200	$6,900	$7,200
Payments for Repurchase of Common Stock	$438,300	$560,900	$134,000	$454,300
Payment, Tax Withholding, Share-based Payment Arrangement	$12,900	$5,700	$2,800	$2,800
Net Cash Provided by (Used in) Financing Activities	$-459,600	$-622,600	$-185,100	$-496,700
Interest Paid, Excluding Capitalized Interest, Operating Activities	$6,000	$500	$300	$300
Income Taxes Paid, Net	$90,800	$71,400	$125,200	$125,200
Capital Expenditures Incurred but Not yet Paid	$53,300	$53,000	$37,900	$28,200
Dividends Payable, Current	$14,800	$15,200	$15,800	$15,800

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("WST","financials")

Full statements spill as a table. For one cell: =jivedata("WST","Revenue") or =jivedata("WST","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.